Company profile SAVA
After 39 days of this quarter the interest is at 6.0. Based on that we can calculate that during remaining 52 days it will total up to 14.0. Cassava Sciences expected interest is significantly lower compared to previous quarter (-57.6%) and same quarter last year (-54.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 3 | 3 0.0% QoQ | 4 33.3% QoQ | 13 225.0% QoQ |
| 2020 | 9 200.0% YoY -30.8% QoQ | 20 566.7% YoY 122.2% QoQ | 17 325.0% YoY -15.0% QoQ | 14 7.7% YoY -17.6% QoQ |
| 2021 | 166 1744.4% YoY 1085.7% QoQ | 46 130.0% YoY -72.3% QoQ | 163 858.8% YoY 254.3% QoQ | 93 564.3% YoY -42.9% QoQ |
| 2022 | 57 -65.7% YoY -38.7% QoQ | 43 -6.5% YoY -24.6% QoQ | 46 -71.8% YoY 7.0% QoQ | 37 -60.2% YoY -19.6% QoQ |
| 2023 | 31 -45.6% YoY -16.2% QoQ | 22 -48.8% YoY -29.0% QoQ | 22 -52.2% YoY 0.0% QoQ | 33 -10.8% YoY 50.0% QoQ |
| 2024 | 6 -80.6% YoY -81.8% QoQ | - | - | - |
The average 5 years interest of Cassava Sciences was 3.25 per week. The last year interest of Cassava Sciences compared to the last 5 years has changed by -43.69%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 226.79%.
After 39 days of this quarter the interest is at 19.0. Based on that we can calculate that during remaining 52 days it will total up to 44.0. Cassava Sciences stock expected interest is significantly higher compared to previous quarter (+131.6%) and same quarter last year (+41.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 4 | 6 50.0% QoQ | 1 -83.3% QoQ | 13 1200.0% QoQ |
| 2020 | 14 250.0% YoY 7.7% QoQ | 17 183.3% YoY 21.4% QoQ | 19 1800.0% YoY 11.8% QoQ | 17 30.8% YoY -10.5% QoQ |
| 2021 | 195 1292.9% YoY 1047.1% QoQ | 68 300.0% YoY -65.1% QoQ | 165 768.4% YoY 142.6% QoQ | 104 511.8% YoY -37.0% QoQ |
| 2022 | 55 -71.8% YoY -47.1% QoQ | 39 -42.6% YoY -29.1% QoQ | 45 -72.7% YoY 15.4% QoQ | 29 -72.1% YoY -35.6% QoQ |
| 2023 | 31 -43.6% YoY 6.9% QoQ | 24 -38.5% YoY -22.6% QoQ | 24 -46.7% YoY 0.0% QoQ | 19 -34.5% YoY -20.8% QoQ |
| 2024 | 19 -38.7% YoY 0.0% QoQ | - | - | - |
The average 5 years interest of Cassava Sciences stock was 3.48 per week. The last year interest of Cassava Sciences stock compared to the last 5 years has changed by -43.68%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 201.54%.
There is not enough data for simufilam drug to provide analysis
There is not enough data for simufilam drug to provide correlation calculation
There is not enough data for simufilam drug to provide analysis
There is not enough data for SavaDx blood-based biomarker to provide analysis
There is not enough data for SavaDx blood-based biomarker to provide correlation calculation
There is not enough data for SavaDx blood-based biomarker to provide analysis
There is not enough data for Cassava Sciences clinical trial to provide analysis
There is not enough data for Cassava Sciences clinical trial to provide correlation calculation
There is not enough data for Cassava Sciences clinical trial to provide analysis
There is not enough data for Cassava Sciences Alzheimer's disease to provide analysis
There is not enough data for Cassava Sciences Alzheimer's disease to provide correlation calculation
There is not enough data for Cassava Sciences Alzheimer's disease to provide analysis
There is not enough data for Cassava Sciences contact to provide analysis
There is not enough data for Cassava Sciences contact to provide correlation calculation
There is not enough data for Cassava Sciences contact to provide analysis
There is not enough data for Cassava Sciences executives to provide analysis
There is not enough data for Cassava Sciences executives to provide correlation calculation
There is not enough data for Cassava Sciences executives to provide analysis
There is not enough data for Cassava Sciences healthcare. to provide analysis
There is not enough data for Cassava Sciences healthcare. to provide correlation calculation
There is not enough data for Cassava Sciences healthcare. to provide analysis